An Analysis of the Changes in the Sarcoma Tumor Immune Microenvironment Following Trabectedin
Status: Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 11 Sep 2019
Price : $35 *
At a glance
- Drugs Trabectedin (Primary)
- Indications Sarcoma
- Focus Pharmacodynamics
- 06 Sep 2019 Status changed from recruiting to withdrawn prior to enrolment.
- 20 Jun 2019 Status changed from suspended to recruiting.
- 03 May 2019 Planned End Date changed from 1 May 2019 to 1 May 2021.